PURPOSE: Cancer incidence rates in Lebanon have been lacking for over three decades. National data based on a total of 4388 cases diagnosed during the year 1998 were reviewed and analyzed. METHODS: Crude and age-standardized rates (ASRs) per 100,000 population were calculated and results were contrasted with estimates from developed and selected developing countries in the region. RESULTS: Among males, bladder (18.5%), prostate (14.2%), and lung cancer (14.1%) were the most frequently reported malignancies. Among females, breast cancer alone accounted for over a third of all cancers, followed by colon cancer (5.8%), and cancer of the corpus uteri (4.8%). Sex-differentials in incidence rates were highest for tobacco-related cancers (lung, larynx, and bladder). Compared with current estimates worldwide, ASRs for bladder cancer in Lebanon showed strikingly high rates. Whereas ASRs for breast and prostate cancer remained lower than those observed in developed countries, they were greater than those estimated from neighboring countries with a similar epidemiological transition as Lebanon. CONCLUSIONS: Findings of the comparative assessments most likely reflect differentials in prevalence of risk factors and lifestyle variables (e.g., lung and breast cancers) and can be partly explained by improvement in cancer detection rate in recent years (for prostate cancer). The implications of the results in light of primary prevention activities, screening practices, and research initiatives in Lebanon are discussed.
PURPOSE:Cancer incidence rates in Lebanon have been lacking for over three decades. National data based on a total of 4388 cases diagnosed during the year 1998 were reviewed and analyzed. METHODS: Crude and age-standardized rates (ASRs) per 100,000 population were calculated and results were contrasted with estimates from developed and selected developing countries in the region. RESULTS: Among males, bladder (18.5%), prostate (14.2%), and lung cancer (14.1%) were the most frequently reported malignancies. Among females, breast cancer alone accounted for over a third of all cancers, followed by colon cancer (5.8%), and cancer of the corpus uteri (4.8%). Sex-differentials in incidence rates were highest for tobacco-related cancers (lung, larynx, and bladder). Compared with current estimates worldwide, ASRs for bladder cancer in Lebanon showed strikingly high rates. Whereas ASRs for breast and prostate cancer remained lower than those observed in developed countries, they were greater than those estimated from neighboring countries with a similar epidemiological transition as Lebanon. CONCLUSIONS: Findings of the comparative assessments most likely reflect differentials in prevalence of risk factors and lifestyle variables (e.g., lung and breast cancers) and can be partly explained by improvement in cancer detection rate in recent years (for prostate cancer). The implications of the results in light of primary prevention activities, screening practices, and research initiatives in Lebanon are discussed.
Authors: Elizabeth Won; Kenneth H Yu; Ali Shamseddine; Leonard Saltz; Deborah Mukherjee; Ali Haydar; Ashwaq El-Olayan; Sally Temraz; Mohamed Naghy; Dorothy Makanjoula; Eileen M O'Reilly; Ghassan K Abou-Alfa Journal: Gastrointest Cancer Res Date: 2013-03
Authors: Zaher K Otrock; Jad Saab; Georges Aftimos; Fady Nasr; Fadi S Farhat; Saad Khairallah; Gérard Abadjian; Marwan Ghosn; Hassan Sidani; Ahmad Ibrahim; Ayman Tawil; Claude Ghorra; Zarouhie Meguerian; Walid Mokaddem; Walid Dayeh; Ziad Salem; Georges Chahine; Nizar Bitar; Anas Mugharbel; Joseph Makdessi; Christina Khater; Mirna El Hajj; Dany Abi Gerges; Charles Sfeir; Joseph Kattan; Khaled Ibrahim; Michel Saade; Hussein Sadek; Rami A Mahfouz; Mohamed A Kharfan-Dabaja; Ghazi Zaatari; Ali Bazarbachi Journal: Pathol Oncol Res Date: 2013-05-08 Impact factor: 3.201
Authors: Cesar Yaghi; Ala-I Sharara; Paul Rassam; Rami Moucari; Khalil Honein; Joseph BouJaoude; Rita Slim; Roger Noun; Heitham Abdul-Baki; Mohamad Khalifeh; Sami Ramia; Raymond Sayegh Journal: World J Gastroenterol Date: 2006-06-14 Impact factor: 5.742
Authors: Wissam H Sleiman Zade Asfahani; Ali T Taher; Denize Al Rahawi; Ismail Khalil Journal: J Thromb Thrombolysis Date: 2005-12 Impact factor: 2.300
Authors: Nagi S El Saghir; Nathalie K Zgheib; Hussein A Assi; Katia E Khoury; Yannick Bidet; Sara M Jaber; Raghid N Charara; Rania A Farhat; Firas Y Kreidieh; Stephanie Decousus; Pierre Romero; Georges M Nemer; Ziad Salem; Ali Shamseddine; Arafat Tfayli; Jaber Abbas; Faek Jamali; Muhieddine Seoud; Deborah K Armstrong; Yves-Jean Bignon; Nancy Uhrhammer Journal: Oncologist Date: 2015-03-16
Authors: Philippe G Aftimos; Elie A Nasr; Dolly I Nasr; Roger J Noun; Fady L Nasr; Marwan G Ghosn; Joelle A El Helou; Georges Y Chahine Journal: Radiat Oncol Date: 2010-06-04 Impact factor: 3.481